Three contract organizations based near the capital of Ohio are starting the year with a multimillion-dollar deal.
The science and technology company Battelle, contract researcher AmplifyBio and CDMO Andelyn Biosciences have netted an eight-year, $149 million indefinite delivery, indefinite quantity contract from the National Institute of Neurological Disorders and Stroke to help advance therapies for treat neurological conditions.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,